Results 131 to 140 of about 5,828,957 (159)
Some of the next articles are maybe not open access.
Post-finasteride Syndrome: A Review of Current Literature
Current Sexual Health Reports, 2018A constellation of persistent adverse effects—collectively termed post-finasteride syndrome (PFS)—after 5α-reductase inhibitor treatment for benign prostatic hyperplasia (BPH) and androgenic alopecia (AGA) has recently been described. The severity of these sexual, physical, neurological, and psychiatric side effects raises important concerns regarding ...
exaly +2 more sources
Trazodone associated with Clomiphene a proposal treatment for post finasteride syndrome
Magna Scientia Advanced Research and Reviews, 2023Erectile dysfunction caused by medications are probably caused by the disconnection of synaptic circuits responsible for linking libido to erection. For instance, it is well known that sexual dysfunction may occur in patients treated with finasteride, an inhibitor of the enzyme 5alpha-reductase, prescribed for androgenetic alopecia and benign prostatic
exaly +2 more sources
Trazodone by epigenetic mechanism can reverse the post finasteride syndrome
Magna Scientia Advanced Research and Reviews, 2023The action mechanism of finasteride as inhibitor of the 5alpha-reductase enzyme in the brain could cause an epigenetic change imbalance in the messenger RNA of androgen receptor. The decrease of dihydrotestosterone (DHT) followed by an increase of free testosterone in the brain could in theory cause an imbalance in acetylation and methylation of ...
exaly +2 more sources
Current Sexual Health Reports, 2018
Post-finasteride syndrome (PFS) is a disorder characterized by a set of clinical symptoms experienced during use or after drug discontinuation. This cluster of symptoms encompasses overall sexual dysfunction (SD), erectile dysfunction (ED), loss of libido, depression, suicidal ideation, anxiety, panic attacks, insomnia, and cognitive dysfunction.
Abdulmaged Traish
exaly +2 more sources
Post-finasteride syndrome (PFS) is a disorder characterized by a set of clinical symptoms experienced during use or after drug discontinuation. This cluster of symptoms encompasses overall sexual dysfunction (SD), erectile dysfunction (ED), loss of libido, depression, suicidal ideation, anxiety, panic attacks, insomnia, and cognitive dysfunction.
Abdulmaged Traish
exaly +2 more sources
Finasteride for hair loss: a review
Journal of Dermatological Treatment, 2022 Background and Objectives Finasteride 1 mg/day is indicated for androgen-dependent conditions such as male androgenetic alopecia (AGA). Methods The literature is comprehensively summarized on the pharmacodynamics, pharmacokinetics, mechanism of action ...
exaly +2 more sources
(135) Post-Finasteride Syndrome: A Case Presentation and Discussion
Journal of the Academy of Consultation-Liaison Psychiatry, 2022Daniel Wesley, Rachel Bronsther
exaly +2 more sources
The post-finasteride syndrome: possible etiological mechanisms and symptoms
International Journal of Impotence Research, 2023Finasteride and dutasteride, synthetic 5α-reductase inhibitors (5ARIs) are recommended in many guidelines for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms and alopecia despite a variety of side effects like sexual, neurological, psychiatric, endocrinological, metabolic and ophthalmological dysfunctions and the increased ...
Herman H. J. Leliefeld +2 more
openaire +2 more sources
Gynäkologische Endokrinologie, 2017
Das Post-Finasterid-Syndrom (PFS) beschreibt eine langfristige Storung der Sexualfunktion sowie psychische und kognitive Veranderungen, die wahrend oder nach der Behandlung einer androgenetischen Alopezie (AGA) mit 1 mg Finasterid pro Tag bzw. wahrend oder nach der Therapie einer benignen Prostatahyperplasie (BPH) mit 5 mg/Tag auftreten und nach ...
Herbert Kuhl, Inka Wiegratz
openaire +1 more source
Das Post-Finasterid-Syndrom (PFS) beschreibt eine langfristige Storung der Sexualfunktion sowie psychische und kognitive Veranderungen, die wahrend oder nach der Behandlung einer androgenetischen Alopezie (AGA) mit 1 mg Finasterid pro Tag bzw. wahrend oder nach der Therapie einer benignen Prostatahyperplasie (BPH) mit 5 mg/Tag auftreten und nach ...
Herbert Kuhl, Inka Wiegratz
openaire +1 more source
The benefits of finasteride for hirsute women with polycystic ovary syndrome or idiopathic hirsutism
Gynecological Endocrinology, 2003 Finasteride has been used frequently), in the treatment of prostate hyperplasia but this drug inhibits 5alpha-reductase and for this reason could be useful for the treatment (of hirsutism.
José Maria Soares-Jr
exaly +4 more sources